Esaxerenone is a non-steroidal mineralocorticoid receptor antagonist used as an antihypertensive agent for the treatment of essential hypertension. This category offers high-quality reference standards… Read more
![Chemical structure of (5S)-1-(2-Hydroxyethyl)-4-methyl-5-[2-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1632002-11-9-5S-1-2-Hydroxyethyl-4-methyl-5-2-trifluoromethylphenyl-1H-pyrrole-3-carboxylic-Acid.png&w=3840&q=75)






![Chemical structure of 6-Methyl-5-(2-(trifluoromethyl)phenyl)-2,3-dihydropyrrolo[2,1-b]oxazole-7-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F6-Methyl-5-2-trifluoromethylphenyl-23-dihydropyrrolo21-boxazole-7-carboxylic-Acid.png&w=3840&q=75)

























Esaxerenone is a non-steroidal mineralocorticoid receptor antagonist used as an antihypertensive agent for the treatment of essential hypertension. This category offers high-quality reference standards essential for pharmaceutical analysis and quality control, supporting laboratories in comprehensive impurity profiling and method validation. Included in this selection are pharmacopeial and non-pharmacopeial impurities, key metabolites such as glucuronide conjugates, and stable isotope-labelled compounds. These materials enable accurate identification and quantification of impurities and degradation products that may arise during drug synthesis or storage. By utilizing these precisely characterized analytical standards, researchers can ensure the safety and efficacy of final drug products while meeting regulatory requirements for pharmaceutical manufacturing. Whether for routine testing or complex investigational studies, these compounds provide the necessary reference data to support the rigorous analytical standards required in modern pharmaceutical development and quality assurance.